Clinical trial MK-3475-012
A phase Ib multi-cohort study of MK-3475 in subjects with advanced solid tumors
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial closed |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | MSD (Merck Sharp & Dohme) |
| EudraCT Identifier | 2012-00577-114 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT01848834 |
| Inclusion criteria | Recurrent or persistent or metastatic tumor |
| Last update |